Treatment for NTM: when, how... and what next?

M. Loebinger (London, United Kingdom), C. Andrejak (Amiens, France)

Source: ERS Course 2015
Number: 3
Disease area: Respiratory infections

PDF journal article, handout or slidesPDF journal article, handout or slides

Rating: 4
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Loebinger (London, United Kingdom), C. Andrejak (Amiens, France). Treatment for NTM: when, how... and what next?. ERS Course 2015

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Asthma control test: how? And where?
Source: Annual Congress 2008 - Asthma control or asthma severity
Year: 2008


TB vaccination: why, when, how and what?
Source: International Congress 2014 – PG20 Global evaluation of tuberculosis from children to adults
Year: 2014




Latent TB: what's next?
Source: Annual Congress 2007 - Latent tuberculosis: what's next?
Year: 2007

Interferon-γ release assays for the diagnosis of active tuberculosis: sensible or silly?
Source: Eur Respir J 2009; 33: 1250-1253
Year: 2009


Screening for lung cancer in a high-risk group: but I still haven't found what I'm looking for...
Source: Eur Respir J 2007; 29: 6-7
Year: 2007


“When you’re at work you’ve got a goal [..] but that’s all finished for me now”; exploring goal perception amongst people with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2017 – Latest insights into chronic care
Year: 2017

Immunotherapy: when, who and which drug?
Source: International Congress 2018 – New drugs, strategies and research designs for advanced non-small cell lung cancer
Year: 2018


TB or not TB... that is the question
Source: International Congress 2019 – CCC Paediatric respiratory diseases
Year: 2019



Tuberculosis situation and control in Europe: where are we and what to do next?
Source: Eur Respir J 2005; 26: Suppl. 49, 476s
Year: 2005

Respiratory disease in the community. Who‘s got what?
Source: Annual Congress 2009 - Diagnostic strategies in primary respiratory care
Year: 2009


Pathology: what do we actually want to know?
Source: Annual Congress 2008 - Multidisciplinary approach in interstitial lung disease
Year: 2008


Intelligent oxygen delivery in the acute setting: “Don't think twice, it's all right”
Source: Eur Respir J, 50 (1) 1701013; 10.1183/13993003.01013-2017
Year: 2017



The integration of respiratory services...Is it the way forward?
Source: Annual Congress 2011 - The COPD patient experience: care and management
Year: 2011


Clustering in asthma: why, how and for how long?
Source: Eur Respir J 2013; 41: 1247-1248
Year: 2013


Cured pulmonary tuberculosis population: what is next?
Source: Virtual Congress 2020 – Pulmonary function and rehabilitation in non-respiratory disease
Year: 2020

Long-term oral antibiotic treatment: why, what, when and to whom?
Source: Eur Respir Monogr 2017; 75: 185-205
Year: 2017


Positional therapy: who, when and how?
Source: Sleep and Breathing Conference 2021
Year: 2021